NEWS & PRESS Archives - Valcare Medical

Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort in Circulation: Cardiovascular Interventions

Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort, by Drs. Melica, Carasso, Butnaru, Gogorishvili, Metreveli, Modine, Kurashvili, Farkash, Meerkin, has been accepted for publication in Circulation: Cardiovascular Interventions. Background: The AMEND implant is a semi-rigid closed D-shaped annuloplasty ring deployed through a transvenous transeptal approach. It is aimed [...]

Samantha Talpir2026-04-12T16:25:21+00:00April 11th, 2026|

Valcare Medical Appoints Two New Members to Board of Directors

WILMINGTON, Del., March 6, 2026 /PRNewswire/ – Valcare Medical, Inc., a pioneer in transcatheter mitral valve repair solutions, today announced the appointment of two new members to its Board of Directors: Jeffrey B. Jump and Jacques Séguin, MD, PhD. These renowned experts in the structural heart and medical device industry will strengthen the Board’s [...]

Samantha Talpir2026-03-06T15:58:15+00:00March 6th, 2026|

Paul Sorajja, M.D. discusses the First-in-America Implantation of AMEND Annuloplasty Ring in Mitral Regurgitation

Listen to Dr. Paul Sorajja, Interventional Cardiologist at Banner University Medical Center Phoenix, describe the first implantation of the AMEND annuloplasty ring via a novel trans-septal system designed to help a leaky mitral valve. Video here: New catheter procedure treats leaky heart valves - Arizona PBS For additional news coverage: Medical breakthrough helps patients [...]

Samantha Talpir2026-03-02T17:26:06+00:00March 2nd, 2026|

How AMEND™ TMVr Annuloplasty System Is Re-engineering Mitral Valve Repair

Watch DeviceTalks host Tom Salemi interview Steve Sandweg CEO and Dr. David Meerkin CMO as they discuss how Valcare’s AMEND™ TMVr Annuloplasty System is re-engineering mitral valve repair. Register here to gain immediate access to view the webinar recording. Webinar Overview Surgical Annuloplasty has long been the gold standard for restoring mitral valve function. [...]

Samantha Talpir2026-03-01T22:06:25+00:00March 1st, 2026|

Valcare Medical Announces First U.S. Transseptal AMEND™ Implant in Early Feasibility Study

WILMINGTON, Del., February 11, 2026 /PRNewswire/ — Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal implantation of its AMEND™ Transcatheter Mitral Valve Repair (TMVr) Annuloplasty System as part of the ongoing AMEND TS Early Feasibility Study (EFS). The milestone procedure was performed by [...]

Samantha Talpir2026-02-14T01:18:46+00:00February 14th, 2026|

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System

HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS). The AMEND™ Trans-Septal System is a trans catheter device intended for treatment [...]

Samantha Talpir2025-03-13T14:18:01+00:00March 13th, 2025|

Valcare Medical, Inc. Expands AMEND TS EU Pilot Study to Italy

TAMPA, Fla., July 25, 2024 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, announces the expansion of the AMEND™ TS EU Pilot Study to Italy. The Italian Ministry of Health has approved the extension to include multiple centers throughout Italy, building upon the initial cases conducted in Portugal earlier this [...]

Samantha Talpir2024-07-25T19:14:53+00:00July 25th, 2024|

Valcare Medical, Inc. Announces Formation of Scientific Advisory Board with Renowned Mitral Valve Experts

TAMPA, Fla., July 2, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished experts. The SAB will provide expert insight and guidance while helping the Company further advance its research and development initiatives for the AMEND mitral valve repair [...]

Samantha Talpir2024-07-02T16:08:32+00:00July 2nd, 2024|

Valcare Medical Announces Enrollment of First Two Patients in AMEND™ TS EU Pilot Study

TAMPA, Fla., May 14, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study. Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital, Portugal, performed the procedures. The purpose of the study is to build upon [...]

Samantha Talpir2024-05-26T20:02:54+00:00May 15th, 2024|

Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO

TAMPA, Fla., April 24, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure by a group of investors led by Techwald Next, aimed at accelerating the company's plans to initiate the AMEND mitral annuloplasty clinical studies in Europe and the United States. As part of the restructuring, TechWald has appointed Steve [...]

Samantha Talpir2024-06-01T21:51:44+00:00April 24th, 2024|